natgillin/translations-raw huggingface dataset:
if you are allergic to tobramycin, to any type of aminoglycoside antibiotic, or to any of the other ingredients of this medicine (listed in section 6).
če ste alergični na tobramicin, na katero koli vrsto aminglikozidnih antibiotikov ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to tocilizumab or any of the other ingredients of this medicine (listed in section 6). if you have an active, severe infection.
če ste alergični na tocilizumab ali katero koli sestavino tega zdravila (navedeno v poglavju 6); če imate aktivno, hudo okužbo.
if you are allergic to tolvaptan or any of the other ingredients of this medicine (listed in section 6)
če ste alergični na tolvaptan ali katero koli sestavino tega zdravila (navedeno v poglavju 6)
if you are allergic to tolvaptan or any of the other ingredients of this medicine (listed in section 6)
če ste alergični na tolvaptan ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to topotecan or any of the other ingredients of this medicine (listed in section 6); if you are breast-feeding.
če ste alergični na topotekan ali katerokoli sestavino tega zdravila (navedeno v poglavju 6). če dojite.
if you are allergic to toremifene or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na toremifen ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
If you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na travoprost ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to travoprost, prostaglandins, timolol, beta-blockers or any of the other ingredients.
če ste alergični (preobčutljivi) na travoprost, prostaglandine, timolol, zaviralce adrenergičnih receptorjev beta ali na katerokoli sestavino zdravila,
If you are allergic to ustekinumab or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na ustekinumab ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
if you are allergic to verteporfin or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na verteporfin ali katero koli sestavino tega zdravila (navedeno v poglavju 6);
if you are allergic to vorapaxar sulfate or any of the other ingredients of this medicine (listed in section 6) if you have severe liver disease
če ste alergični na vorapaksarjev sulfat ali katero koli sestavino tega zdravila (navedeno v poglavju 6), če imate hudo bolezen jeter.
If you are allergic to voriconazole or any of the other ingredients of this medicine (listed in section 6).
Če ste alergični na vorikonazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
If you are allergic to voriconazole or any of the other ingredients of this medicine (listed in section 6).
Če ste alergični na vorikonazol ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to vortioxetine or any of the other ingredients of this medicine (listed in section 6). if you are taking other medicines for depression known as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors.
če ste alergični na vortioksetin ali katero koli sestavino tega zdravila (navedeno v poglavju 6). če jemljete druga zdravila za zdravljenje depresije, imenovana neselektivni zaviralci monoaminooksidaze ali selektivni zaviralci MAO-A.
if you are allergic to vortioxetine or any of the other ingredients of this medicine (listed in section 6). if you are taking other medicines known for depression as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors.
če ste alergični na vortioksetin ali katero koli sestavino tega zdravila (navedeno v poglavju 6). če jemljete druga zdravila za zdravljenje depresije, imenovana neselektivni zaviralci monoaminooksidaze ali selektivni zaviralci MAO-A.
if you are allergic to zaleplon or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na zaleplon ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to zoledronic acid, another bisphosphonate (the group of substances to which zoledronic acid belongs), or any of the other ingredients of this medicine (listed in section 6). if you are breast-feeding.
če ste alergični na zoledronsko kislino, kak drug difosfonat (skupina snovi, ki ji pripada zoledronska kislina) ali katero koli sestavino tega zdravila (navedeno v poglavju 6). če dojite.
if you are allergic to zoledronic acid, other bisphosphonates or any of the other ingredients of this medicine (listed in section 6).
če ste alergičn na zoledronsko kislino, druge difosfonate ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
if you are allergic to zoledronic acid, other bisphosphonates or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na zoledronsko kislino, druge difosfonate ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
if you are allergic to zoledronic acid, other bisphosphonates or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na zoledronsko kislino, druge difosfonate ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
if you are allergic to zoledronic acid, other bisphosphonates or any of the other ingredients of this medicine (listed in section 6).
če ste alergični na zoledronsko kislino, druge difosfonate ali katerokoli sestavino zdravila Zoledronska kislina Teva Generics (navedeni v poglavju 6).
If you are allergic to:
če ste alergični na :
if you are allergicto irbesartan or any other ingredients of this medicine (listed in section 6) if you are more than 3 months pregnant. (It is also better to avoid Karvea in early pregnancy – see pregnancy section)
če ste alergični na irbesartan ali katerokoli sestavino tega zdravila (navedeno v poglavju 6) če ste noseči dlje kot tri mesece. (Jemanju zdravila Karvea se je bolje izogniti tudi med zgodnjo nosečnostjo – glejte poglavje o nosečnosti)
If you are already being treated and will continue your treatment with:
če se že zdravite ali boste nadaljevali zdravljenje s:
If you are already being treated with phenytoin, your blood concentration of phenytoin will need to be monitored during your treatment with Voriconazole Hospira and your dose may be adjusted.
Če se že zdravite s fenitoinom, je treba med zdravljenjem z zdravilom Vorikonazol Hospira nadzirati koncentracijo fenitoina v krvi in morda prilagoditi odmerek.
If you are already pregnant, it will not interrupt an existing pregnancy.
Če ste že noseči, ne bo prekinilo obstoječe nosečnosti.
If you are already pregnant, or think that you might be, talk to a doctor as soon as you can.
Če ste že noseči ali menite, da bi lahko bili noseči, se nemudoma posvetujte z zdravnikom.
If you are already taking a non-steroidal anti-inflammatory drug (NSAID) and/or corticosteroids, you may continue to take them after starting Leflunomide ratiopharm.
Če že jemljete nesteroidna protivnetna zdravila (NSAID) ali kortikosteroide ali oboje, lahko z njimi nadaljujete tudi po začetku uporabe zdravila Leflunomid ratiopharm.
If you are already taking a nonsteroidal anti-inflammatory drug (NSAID) and/or corticosteroids, you may continue to take them after starting Leflunomide ratiopharm.
Če že jemljete nesteroidna protivnetna zdravila (NSAID) ali kortikosteroide ali oboje, lahko z njimi nadaljujete tudi po začetku uporabe zdravila Leflunomid ratiopharm.
If you are already taking a nonsteroidal anti-inflammatory drug (NSAID) and/or corticosteroids, you may continue to take them after starting Leflunomide Winthrop.
Če že jemljete nesteroidna protivnetna zdravila (NSAID) ali kortikosteroide ali oboje, lahko z njimi nadaljujete tudi po začetku uporabe zdravila Leflunomid Winthrop.
If you are already taking another medicine that contains lamivudine for HIV infection, your doctor will continue to treat you with the higher dose, (usually 150 mg twice a day), because the dose of lamivudine in Lamivudine Teva (100 mg) is not enough to treat HIV infection.
Če že jemljete kakšno drugo zdravilo, ki vsebuje lamivudin, za zdravljenje okužbe s HIV, vas bo zdravnik še naprej zdravil z višjim odmerkom (po navadi 150 mg dvakrat na dan), ker odmerek lamivudina v zdravilu Lamivudin Teva (100 mg) ne zadošča za zdravljenje okužbe s HIV.
If you are already taking both dapagliflozin and metformin as single tablets, your doctor may ask you to switch to this medicine.
Če že jemljete dapagliflozin in metformin v obliki ločenih tablet, vam bo zdravnik morda naročil, da preidete na to zdravilo.
if you are already taking other medicines for the treatment of diabetes. if you have problems with your enzyme called Glucose-6-phosphodehydrogenase since it can decrease your red cells.
če že jemljete druga zdravila za zdravljenje sladkorne bolezni. če imate težave z encimom, imenovanim glukoza-6-fosfodehidrogenaza, ker lahko le-ta zmanjša število rdečih krvnih telesc.
If you are already taking rifabutin, you will need a blood test and you will need to look out for some possible side effects of rifabutin.
Če že jemljete rifabutin, boste morali opraviti preiskavo krvi in biti pozorni na nekatere možne neželene učinke rifabutina.
If you are already taking the following medicines:
če že jemljete naslednja zdravila:
if you are already undergoing other treatments for erectile dysfunction. if you are already undergoing treatments for pulmonary arterial hypertension (PAH) containing sildenafil or any other PDE5 inhibitors.
če prejemate druge oblike zdravljenja za erektilno disfunkcijo, če se zaradi pljučne arterijske hipertenzije (PAH) že zdravite z zdravili, ki vsebujejo sildenafil ali katere koli druge zaviralce PDE5.
If you are also taking a sulfonylurea (such as glimepiride or glibenclamide), your doctor may tell you to test your blood sugar levels.
Če hkrati jemljete tudi sulfonilsečnino (na primer glimepirid ali glibenklamid), vam bo zdravnik morda naročil, da si merite koncentracijo krvnega sladkorja.
If you are also taking a sulphonylurea (such as glimepiride or glibenclamide), your doctor may tell you to lower your sulphonylurea dose depending on your blood sugar levels.
Če se sočasno zdravite s sulfonilsečnino (kot sta glimepirid ali glibenklamid), lahko zdravnik odmerek sulfonilsečnine zmanjša, odvisno od koncentracije krvnega sladkorja.
If you are also taking an antacid such as aluminium/magnesium hydroxide or calcium carbonate, or a multivitamin supplement, take it at least 4 hours before or at least 4 hours after Vitekta.
Če jemljete tudi antacid, kot je aluminijev/magnezijev hidroksid ali kalcijev karbonat ali multivitaminsko dopolnilo, ga vzamite vsaj 4 ure pred uporabo zdravila Vitekta ali najmanj 4 ure po tem.
If you are also taking didanosine, take it at least 1 hour before or at least 2 hours after Vitekta.
Če jemljete tudi didanozin, ga vzemite vsaj 1 uro pred uporabo zdravila Vitekta ali najmanj 2 uri po tem.
If you are also taking medicines to prevent blood clots there is a greater risk of bleeding.
Če jemljete tudi zdravila za preprečevanje nastanka krvnih strdkov, obstaja večje tveganje za pojav krvavitev.
If you are also taking other medicines:
Če jemljete tudi druga zdravila:
If you are also taking ritonavir, then you can take CRIXIVAN at any time of the day with or without food.
Če jemljete tudi ritonavir, lahko vzamete zdravilo CRIXIVAN kadar koli v dnevu z ali brez hrane.
If you are also using estrogen patches, make sure that the Intrinsa patch and the estrogen patch do not overlap.
Če uporabljate tudi estrogenske obliže, pazite, da se ta obliž zdravila Intrinsa in estrogenski obliž ne prekrivata.
If you are also using estrogen patches, make sure that the Livensa patch and the estrogen patch do not overlap.
Če uporabljate tudi estrogenske obliže, pazite, da se ta obliž zdravila Livensa in estrogenski obliž ne prekrivata.
if you are also using medicines with heart toxicity
če se sočasno zdravite z zdravili, ki lahko toksično delujejo na srce;
if you are an adolescent and your skeleton is not yet fully formed (still growing).
če ste mladostnik in vaš skelet še ni dokončno oblikovan (če še rastete);
If you are an adult and have problems with your kidneys, your doctor may advise you to reduce your daily dose of the granules.
Če ste odrasla oseba in imate ledvične težave, vam bo zdravnik morda svetoval zmanjšanje dnevnega odmerka zrnc.
If you are an adult and have problems with your kidneys, your doctor may advise you to take Viread less frequently.
Če ste odrasla oseba in imate ledvične težave, vam bo zdravnik morda svetoval, da jemljete zdravilo Viread manj pogosto.
if you are an adult who has or had a history of substance abuse (e.g. alcohol or drugs) if you have psoriasis, it may get worse during treatment with Pegasys. if you have a problem with your liver other than hepatitis B or C.
če ste odrasli in imate ali ste imeli v anamnezi zlorabo psihoaktivnih substanc (alkohol ali droge), če imate psoriazo, ki se lahko med zdravljenjem z zdravilom Pegasys poslabša, če imate težave z jetri in vzrok ni hepatitis B ali C,
If you are an athlete, using PecFent may result in positive doping-tests.
Če ste športnik, lahko uporaba zdravila PecFent povzroči pozitivne teste na nedovoljena poživila (doping).
If you are an intermediate metaboliser or extensive metaboliser:
Če ste vmesni presnavljalec ali hitri presnavljalec:
If you are at a high risk of bleeding, your doctor may decide to reduce your dose to 0.5 mg per kg of body weight or 0.75 mg per kg of body weight.
Če pri vas obstaja veliko tveganje za krvavitev, vam bo zdravnik morda odmerek zmanjšal na 0,5 mg na kilogram telesne mase ali na 0,75 mg na kilogram telesne mase.
if you are at high risk of bleeding (for example): you have had surgery within the last twelve hours before you receive Xigris, or you are bleeding from a previous surgery, or you might have surgery while you receive Xigris
če je pri vas povečano tveganje za krvavitev (na primer): če so vam v zadnjih dvanajstih urah pred prejemanjem zdravila Xigris opravili operacijski poseg, če krvavite od predhodnega operacijskega posega ali bi lahko med prejemanjem zdravila Xigris potrebovali operacijo
If you are at higher risk of seizures (see Section 2), talk to your doctor.
Če je pri vas večje tveganje za pojav napadov krčev (glejte poglavje 2), se morate posvetovati s svojim zdravnikom.
If you are at risk for a certain type of abnormal heart rhythm (e.g. torsade de pointes or QTc prolongation), your heart will be monitored continuously.
Če obstaja tveganje določene vrste nenavadnega bitja srca (npr. aritmija torsade de pointes ali podaljšanja Q-Tc), bo vaše srce pod neprestanim nadzorom.
if you are at risk of bleeding– for example, if you have an active ulcer of the stomach or of the first part of the small intestine (duodenal ulcers), if you have suffered a physical injury (trauma), if you are at risk of bleeding within the skull,
če pri vas obstaja tveganje za krvavitve – npr. če imate aktivno razjedo želodca ali začetnega dela tankega črevesa (duodenalni ulkus), če ste imeli telesno poškodbo (travmo) ali če pri vas obstaja tveganje za krvavitve znotraj lobanje,
If you are at risk of blood clots or if blood clots are common in your family.
Če imate tveganje za nastajanje krvnih strdkov ali če so krvni strdki v vaši družini pogosti.
if you are at risk of blood clots. if you have severe kidney disease.
če imate tveganje za pojav krvnih strdkov, če imate hudo bolezen ledvic.
If you are at risk of developing diabetes, your doctor will need to monitor your blood sugar level during therapy with somatropin.
Če obstaja tveganje, da se razvije sladkorna bolezen, bo moral zdravnik med zdravljenjem s somatropinom nadzirati vaše vrednosti sladkorja v krvi.
if you are at risk of heart disease, this includes high blood pressure, high cholesterol, diabetes, smoking.
če imate tveganje za bolezen srca, ki vključuje zvišan krvni tlak, zvišan holesterol, sladkorno bolezen in kajenje
if you are at risk of heart disease, this includes high blood pressure, high cholesterol, diabetes, smoking.
če imate tveganje za bolezen srca, ki vključuje zvišan krvni tlak, zvišan holesterol, sladkorno bolezen in kajenje,
If you are at risk of or are a carrier of or have active HEPATITIS B VIRUS (HBV) infection, Cimzia may increase the risk of reactivation in people who carry this virus.
Če pri vas obstaja tveganje za okužbo z VIRUSOM HEPATITISA B (HBV), če ste njegov prenašalec ali pa imate aktivno okužbo, lahko pri osebah, ki so prenašalci virusa, zdravilo Cimzia poveča tveganje reaktivacije.
if you are awaiting a liver transplant;
če čakate na presaditev jeter;
If you are being treated for actinic keratosis
Če se zdravite zaradi aktinične keratoze
If you are being treated for actinic keratosis
Če se zdravite zaradi aktinične keratoze:
if you are being treated for an eye disease called narrow angle glaucoma
če vas zdravijo zaradi očesne bolezni, imenovane glavkom z zaprtim zakotjem;
If you are being treated for basal cell carcinoma or actinic keratosis follow these additional precautions:
Če se zdravite zaradi karcinoma bazalnih celic ali aktiničnih keratoz, upoštevajte naslednje dodatne previdnostne ukrepe:
If you are being treated for basal cell carcinoma:
Če se zdravite zaradi karcinoma bazalnih celic
If you are being treated for basal cell carcinoma:
Če se zdravite zaradi karcinoma bazalnih celic:
If you are being treated for cervical cancer, you may get side effects from the other medicine (cisplatin) that you will be given along with Topotecan Teva.
Če se zdravite zaradi raka materničnega vratu, se lahko pojavijo neželeni učinki drugega zdravila (cisplatina), ki ga boste prejeli skupaj z zdravilom Topotekan Teva.
If you are being treated for chronic lymphocytic leukaemia
Če se zdravite zaradi kronične limfocitne levkemije
If you are being treated for CML:
Če se zdravite zaradi KML:
If you are being treated for DFSP:
Če se zdravite zaradi DFSP:
If you are being treated for genital warts follow these additional precautions:
Če se zdravite zaradi bradavic, upoštevajte naslednje dodatne previdnostne ukrepe:
If you are being treated for genital warts:
Če se zdravite zaradi genitalnih bradavic
If you are being treated for genital warts:
Če se zdravite zaradi genitalnih bradavic:
If you are being treated for GIST or MRCC, the usual dose is 50 mg once daily taken for 28 days (4 weeks), followed by 14 days (2 weeks) of rest (no medicine), in 6-week cycles.
Če se zdravite zaradi gastrointestinalnega stromalnega tumorja (GIST) ali raka ledvic (MRCC), običajni odmerek znaša 50 mg enkrat na dan, 28 dni (4 tedne), čemur sledi 14 dni (2 tedna) premora (brez zdravila), tako da celotni ciklus traja 6 tednov.
If you are being treated for GIST:
Če se zdravite zaradi GIST:
If you are being treated for granulomatosis with polyangiitis or microscopic polyangiitis
Če se zdravite zaradi granulomatoze s poliangiitisom ali mikroskopskega poliangiitisa
If you are being treated for granulomatosis with polyangiitis or microscopic polyangiitis Treatment with MabThera uses four separate infusions given at weekly intervals.
Če se zdravite zaradi granulomatoze s poliangiitisom ali mikroskopskega poliangiitisa Zdravljenje z zdravilom MabThera obsega štiri ločene infuzije, ki jih dobite v presledkih enega tedna.
If you are being treated for HES/CEL:
Če se zdravite zaradi HES/CEL:
If you are being treated for HIV infection your doctor will prescribe Truvada with other antiretroviral medicines.
Če se zdravite zaradi okužbe s HIV, vam bo zdravnik predpisal zdravilo Truvada skupaj z drugimi protiretrovirusnimi zdravili.
If you are being treated for Kaposi’sarcoma, Caelyx will be administered at a dose of 20 mg per square metre of your body surface area (based on your height and weight).
Če se zdravite zaradi Kaposijevega sarkoma, boste zdravilo Caelyx prejeli v odmerku 20 mg na kvadratni meter vaše telesne površine (izračunane na podlagi vaše telesne višine in mase).
If you are being treated for MDS/MPD:
Če se zdravite zaradi MDS/MPD:
if you are being treated for more than one injury following a serious accident if you have sudden serious breathing problems
če vas zdravijo zaradi več kot ene poškodbe, ki ste jo dobili v hudi nesreči če imate nenadne resne težave pri dihanju
if you are being treated for more than one injury following a serious accident; if you experience sudden serious breathing problems.
če se zdravite zaradi več kot ene poškodbe po hudi nesreči. če se pojavijo nenadne težave z dihanjem.
If you are being treated for multiple myeloma, and have already received at least 1 prior therapy, Caelyx will be administered at a dose of 30 mg per square metre of your body surface area (based on your height and weight) as a 1 hour intravenous infusion on day 4 of the bortezomib 3 week regimen immediately after the bortezomib infusion.
Če se zdravite zaradi diseminiranega plazmocitoma in ste že prejeli najmanj 1 vrsto predhodnega zdravljenja, vam bodo zdravilo Caelyx dali v odmerku 30 mg na kvadratni meter telesne površine (ta pa je odvisna od vaše telesne višine in mase) v obliki enourne intravenske infuzije na 4. dan 3- tedenske sheme zdravljenja z bortezomibom, in sicer takoj po infuziji bortezomiba.
If you are being treated for non-Hodgkin’s Lymphoma
Če se zdravite zaradi ne-Hodgkinovega limfoma
If you are being treated for non-Hodgkin’s Lymphoma or chronic lymphocytic leukaemia
Če se zdravite zaradi ne-Hodgkinovega limfoma ali kronične limfocitne levkemije
If you are being treated for parathyroid cancer or primary hyperparathyroidism
Če se zdravite zaradi raka na obščitnici ali primarnega hiperparatiroidizma
If you are being treated for parathyroid cancer or primary hyperparathyroidism The usual starting dose for Mimpara is 30 mg (one tablet) twice per day.
Če se zdravite zaradi raka na obščitnici ali primarnega hiperparatiroidizma Običajni začetni odmerek zdravila Mimpara je 30 mg (ena tableta) dvakrat na dan.
If you are being treated for Ph-positive ALL:
Če se zdravite zaradi Ph pozitivne ALL:
If you are being treated for Ph-positive ALL:
Če se zdravite zaradi Ph-pozitivne ALL:
If you are being treated for pNET, the usual dose is 37.5 mg once daily without a rest period.
Če se zdravite zaradi nevroendokrinega tumorja trebušne slinavke (pNET), običajni odmerek znaša 37,5 mg enkrat na dan brez obdobja premora.
If you are being treated for rheumatoid arthritis
Če se zdravite zaradi revmatoidnega artritisa
If you are being treated for rheumatoid arthritis, you will also find this information in the Patient Alert Card you have been given by your doctor.
Če se zdravite zaradi revmatoidnega artritisa, boste te podatke našli tudi na opozorilni izkaznici za bolnika, ki vam jo je dal vaš zdravnik.
If you are being treated for secondary hyperparathyroidism
Če se zdravite zaradi sekundarnega hiperparatiroidizma
If you are being treated for the prevention of bone complications due to bone metastases, you will be given one infusion of Zoledronic Acid Accord every three to four weeks.
Če prejemate zdravilo za preprečevanje zapletov na kosteh zaradi kostnih metastaz, boste prejeli eno infuzijo zdravila Zoledronska kislina Accord vsake tri do štiri tedne.
If you are being treated for the prevention of bone complications due to bone metastases, you will be given one infusion of Zoledronic acid Actavis every three to four weeks.
Če zdravilo dobivate za preprečevanje zapletov na kosteh zaradi kostnih metastaz, boste dobivali po eno infuzijo zdravila Zoledronska kislina Actavis na tri do štiri tedne.
If you are being treated for the prevention of bone complications due to bone metastases, you will be given one infusion of Zoledronic Acid Hospira every three to four weeks.
Če prejemate zdravilo za preprečevanje zapletov na kosteh zaradi kostnih metastaz, boste prejeli eno infuzijo zdravila Zoledronska kislina Hospira vsake tri do štiri tedne.
If you are being treated for the prevention of bone complications due to bone metastases, you will be given one infusion of Zoledronic acid medac every three to four weeks.
Če prejemate zdravilo za preprečevanje zapletov na kosteh zaradi kostnih metastaz, boste prejeli eno infuzijo zdravila Zoledronska kislina medac vsake tri do štiri tedne.